medigraphic.com
SPANISH

Archivos de Investigación Materno Infantil

ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 3

<< Back Next >>

Arch Inv Mat Inf 2009; 1 (3)

Prueba de tolerancia oral a la glucosa modificada por Carpenter en puérperas con macrosomía fetal como diagnóstico de diabetes gestacional

Díaz MLA, Herrera VJE, Quiroga HA
Full text How to cite this article

Language: Spanish
References: 11
Page: 132-137
PDF size: 155.50 Kb.


Key words:

Gestational diabetes, macrosomic fetus, tries oral tolerance to the glucose modified by Carpenter.

ABSTRACT

Objective: To establish proof of oral glucose tolerance modified by Carpenter with macrosomic fetus as diagnosis gestational Diabetes. Materials and methods: With an observational study, a prospective, cross-sectional, case-control puerpera 112 women were evaluated at the Hospital Materno Infantil ISSEMyM, under informed consent was made an initial determination and two subsequent (interval 1 and 2 hours) to the oral ingestion of a load of 100 g of glucose to all patients in the early postpartum period, 48 hours there to and with a history of fetuses with greater weight to the 90 percentile for cases and those between 10 and 90 percentile for the controls, according table Betaglia (NOM 007). We used the formula as modified by Carpenter and was established as proof positive values greater than or equal to 110 mg/dL, focused information in a database program SPSS version 14, developed histograms and graphs, as well as assessment of the sensitivity and specificity. Results: The 112 patients puerperal women with a minimum age of 18 years and maximum of 49 years. Identifying an average of fetal weight of 4,029 g and increased weight during pregnancy of 14 kg in the case group, the group controls was an average of fetal weight of 3,180 g. And an average increase in weight during pregnancy of 12 kg. Taking an odds ratio of 7.8 with a history of macrosomic fetus and 1 in previous deaths. We obtained 45 positive cases (glucose greater than 110 mg/dL) in the case group and 12 positive cases in the control group and validation of the test fearlessness sensitivity of 80.4% and specificity of 78.6% with a positive predictive value of 78.9 and a negative predictive value of 80.0%, with an odds ratio of 15%. Conclusions: Evidence of oral glucose tolerance in the postpartum period is modified by Carpenter quickly and effectively determines that the possibility of the completion of gestational diabetes by 80%, accepted our hypothesis. The background inherit family diabetes mellitus, macrosomic fetus previous deaths, BMI and weight gain during pregnancy are important risk factors. Suggestions: Perform test oral glucose modified by Carpenter within the first 48 hours to detect macrosomic product.


REFERENCES

  1. Chiquete E, Nuño GP, Pandero CA. Perspectiva histórica de la diabetes mellitus. Comprendiendo la enfermedad. Investigación en Salud, Universidad de Guadalajara, México. 2001; III: 4-10.

  2. Henry OJ. Embarazo y metabolismo de los carbohidratos. Rev Colombiana de Obstetricia y Ginecología 2003; 54 (2): 97-106.

  3. Rodríguez SJ, Vega ME. Panorama de la diabetes gestacional. Diabetes hoy para el médico y el profesional de la salud. 2004; 6: 1320-22.

  4. Maslovitz S, Shimonovitz S, Lessing JB, Hochner-Celnikier D. The validity of oral glucose tolerance test after 36 weeks´ gestation. Euro J Obst & Gynecol and Rep Bio 2006; 129: 19-24.

  5. Fadl H, Östlund I, Nilsson K, Hanson U. Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG 2006; 113: 1067-1071.

  6. Sacks DA, Chen W, Wolde-Tsadick G, Buchanan TA. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Am Col Obstet Gynecol 2003; 101 (6): 1197-1203.

  7. Sacks DA, Chen W, Wolde-Tsadick G, Buchanan TA. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Am Col Obstet Gynecol 2003; 101 (6): 1197-1203.

  8. Hollander MH, Parlberg KM, Huisjes AJM. Gestational diabetes: A review of the current literature and guidelines. Obst and Gynecol Surv 2007; 52 (2): 125-136.

  9. 9 Ramírez TMA. Diabetes mellitus gestacional. Experiencia en una institución de tercer nivel de atención. Ginecol Obstet Mex 2005; 73: 484-491.

  10. Cárdenas J. Prueba de tolerancia oral a la glucosa modificada en puérperas como diagnóstico retrospectivo de diabetes gestacional Anales de la Facultad de Medicina Universidad Nacional Mayor de San Marcos 2004; 65(1): 7-13.

  11. Smirnakis KV, Chasan-Taber L, Wolf M, Markenson G, Ecker JL, Thadhani R. Postpartum diabetes screening in women with a history of gestational diabetes. Am Colleg Obstet and Gynecol 2005; 106 (6): 1297-1307.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Inv Mat Inf. 2009;1